A coalition of 18 pharma companies located in India, China, Bangladesh and South Africa that manufacture generic drugs have pledged to work together to accelerate access to millions of doses of new interventions for COVID-19 for low- and middle-income countries. A coalition of 18 pharma companies located in India, China, Bangladesh and South Africa that … Continue reading Eight Indian generic drug companies join international coalition, pledge to make COVID-19 drugs
Sun Pharmaceuticals
Sun Pharma, NIV to jointly test drugs for Zika, chikungunya and dengue
Sun Pharmaceutical Industries Ltd and the National Institute of Virology (NIV), Pune signed an agreement for testing phytopharmaceutical, biologic and chemical entities developed by Sun Pharma against Zika, chikungunya and dengue viruses. Sun Pharma will provide drug molecules to NIV for testing against Zika, chikungunya and dengue viruses. “A couple of interesting phytopharmaceutical candidates against … Continue reading Sun Pharma, NIV to jointly test drugs for Zika, chikungunya and dengue
Editorial: An unhealthy practice
Published in The Hindu on November 13, 2007 Four years after Mumbai-based Sun Pharmaceuticals was found unauthorisedly promoting and marketing letrozole, a drug prescribed for advanced breast cancer in postmenopausal women, for treating infertility in women, it has been cleared by the Indian Drugs Controller-General for that very purpose. What is shocking is that this … Continue reading Editorial: An unhealthy practice
Science Chronicle 